The Medical Library Association (MLA) held its 118th annual meeting in Atlanta, Georgia, May 18–23, 2018, at the Hyatt Regency Atlanta. The meeting theme was “Adapting, Transforming, Leading.” Total attendance for the meeting was 1,670, with 236 participating in continuing education courses. Additional meeting content—including the meeting program and various electronic presentations from the business meeting, plenary sessions, poster sessions, and program sessions—can be accessed by all meeting registrants via the MLA ’18 website.Executive Director Kevin Baliozian welcomed attendees and gave a pre-session announcement about a suicide in the hotel in a public area the night before. He discussed the steps MLA was taking to reach out to members who had been present as well as counseling services provided by the hotel. He then introduced MLA President Barbara A. Epstein AHIP, FMLA.MLA President Barbara A. Epstein, AHIP, FMLA, welcomed attendees to the 2018 annual meeting. She updated the audience on a change to the meeting format in regard to how awards would be given out over a series of sessions, rather than all at once, and encouraged everyone to attend the plenary sessions and visit with vendors throughout the meeting. President Epstein then introduced Connie K. Machado, AHIP, who welcomed attendees on behalf of the Southern Chapter.Connie K. Machado, AHIP: Good morning and welcome. The Southern Chapter and all its members extend a warm welcome to you in beautiful downtown Atlanta on behalf of MLA for this 118th annual meeting. Many of our local Southern Chapter members have worked with MLA to plan this exciting meeting and venue for all of you in attendance. We hope that you are able to adapt to our humidity and temperatures while you’re here in the South.Founded in 1951, the Southern Regional Group later transformed to the Southern Chapter and has hosted three MLA meetings in this region. It has been seventeen years since the last meeting, which was held in Orlando, and we welcome you back with our warm Southern charm, great food, and hospitality. The Southern Chapter has a reputation for having fun and hosting great social events, so we hope you take some of our spirit of Southern hospitality home with you.Throughout the Southern Chapter’s rich history, many of our founding librarians have served as MLA president and in other positions as leaders. Names like Eileen Cunningham, Mildred Crow Langner, and Mary Louise Marshall, as well as William (Bill) Postel, Alfred N. Brandon, Mildred Jordan, T. Mark Hodges, and a host of others. And I’m sure that there will be more leaders to come in the future.Most of you have passed through Atlanta when traveling, at least at the airport. But there is much more to see and absorb here in the city’s rich history. Southern Chapter members are pleased to welcome you to Atlanta, home to the Centers for Disease Control and Prevention (CDC), Coca-Cola, and CNN, and plenty of dining experiences and fun places to visit during your stay. They also have seventy-five streets with the name “Peach” in it, so navigate carefully. So, again, I welcome you on behalf of the Southern Chapter members and MLA.Now, please join me in welcoming these truly creative and dedicated members who have spent more than three years planning this Atlanta meeting: the 2018 National Program Committee (NPC) Cochair David A. Nolfi, AHIP; 2018 NPC Cochair Debra Berlanstein, AHIP; 2018 Local Assistance Committee Chair Sandra G. Franklin, AHIP, FMLA; and 2018 Local Assistance Committee Cochair Joe Swanson Jr. Let’s give them a big hand.David A. Nolfi, AHIP: Thank you, Connie. On behalf of the MLA 2018 National Program Committee and the Local Assistance Committee, we officially welcome you to Atlanta, the first time for the MLA annual meeting. Our theme, “ATL: Adapting, Transforming, Leading,” reflects both this vibrant city and the spirit of our membership. The rising phoenix in our logo reflects the rise of Atlanta to become the dynamic leader in commerce, health care, research, education, and entertainment that it is today.Debra Berlanstein, AHIP: As medical librarians, we too, are continually evolving and searching for innovative ways to grow, change, reimagine, and most of all, make a difference. We know you will be inspired by the programming and the many opportunities to connect and share with colleagues during your stay in this amazing city. We hope you will get out and about and explore the world outside the doors of the Hyatt Regency Atlanta.David Nolfi: Planning this meeting over the last two years gave us the privilege of working with a great group of enthusiastic librarians whose hard work, energy, and commitment made cochairing the committee a pleasure. And so I ask now, would the members of the National Program Committee as well as the MLA staff who worked on the meeting please stand to be recognized. And now I ask you to please welcome Sandra Franklin, chair of the Local Assistance Committee, and Joe Swanson Jr., cochair.Candide, by Leonard Bernstein.Joe Swanson Jr.: Welcome to Atlanta. We’re so glad that you’re here and we hope you have an enjoyable time. We want you to enjoy the sessions and so forth. But in the meantime, we want you to have a little fun. We know that some of you have already been out and about, but you can visit places like the botanical gardens, the Jimmy Carter Library and Museum. You’ve already been around the attractions at the Centennial Olympic Park. And the Atlanta Symphony Orchestra will be performing Applause.]So, as I said, we want you to enjoy the meeting, but in your spare time and for those who are going beyond the meeting, enjoy the city. And come back to see us! We have what we call Southern hospitality here. Thank you.  They’re scattered hither and yon, but just thank them if they’re near you.In addition to that, I’d like to thank personally everyone who has worked on this committee, but especially our Local Assistance Committee. They each had their tasks, they did their tasks and just did a fantastic job, and you’re seeing the results of that. So I’d like all of them to stand. Please stand [and be recognized] for this 2018 meeting. , in building stronger relationships between these groups. And if you don’t know what the NIH All of Us research program is, plan to be here on Wednesday morning to hear Dr. Dara Richardson-Heron.This is an initiative of MLA and the Public Library Association, and it is funded by the National Network of Libraries of Medicine (NNLM) and the NIH All of Us research program. And this unique partnership allows us to leverage the expertise of our members, of you And third, my family. We have two great daughters who married two great sons-in-law, who brought us four terrific grandchildren. And the littlest one is Hartley, who was born just last month, and she’s still tiny. She’s eating a lot, she’s more than eight pounds now, and we expect her to grow into her hair bows very soon. [Applause.]And last but not least, my husband, Arnold. Through the years, he has been my confidante, my sounding board, my gentle critic, my press agent, my legal advisor, my best friend, and my secret sauce. I have dragged him to a few MLA meetings, and I have to say he sometimes enjoys them way more than I do. Last night, he came back from the exhibit opening with just a whole bagful of stuff that he collected and a list of people he talked to. And I think marrying him was the best decision I ever made. Thank you. If you have any questions, you’re welcome to email Cujo, my dog, and he will respond to you, or you can email me or Ray, whatever you prefer. Thank you for all of your time.  Why has it increased? Because of new programming, like the InSight Initiative, sponsored by the participating organizations, that allowed us to have the librarian attendees attend for free and pay for travel expenses, which is great.That number has increased by an impressive $46,000 this year, affecting 150 individuals. And lastly, after this meeting, vacation and kind of a zen in Canada on Lake Huron. And so between the graduation and that, I’ve had the pleasure of being here and meeting all of you. Thank you.  Now, I hope most of you know who Chef Ramsay [Gordon Ramsay of Hell’s Kitchen] is, because if you don’t, this won’t make any sense at all. And anyway, what does that have to do with libraries, you say? Well, nothing. But it does have an analogy to what I want to say.So, I’ve titled this time with you today: If Chef Ramsay was coming to your house, would you cook? So, I’m in the kitchen, but I’m not necessarily the expert. We, collectively, are the experts. And if Chef Ramsay was coming to my house, heck, no, I wouldn’t cook, because he scares me. But I’m not afraid of you, because you are all my colleagues, and I feel comfortable in saying this: In the 120th year of the association, I am proud and honored to be the first African American president of the Medical Library Association. We are changing. We are becoming a more diverse society. But our profession has not yet caught up to that. And I want to thank Elaine R. Martin, as she so beautifully articulated that yesterday in her Doe lecture, so thank you Elaine. You said everything I wanted to say and didn’t have time. So, over the next year, I want you to remain calm, I want you to remain open, I want you to remain flexible, and I want you to remain positive. As we’re sitting in this room here in Atlanta—the home of Coke, fried foods, grits, and pie—we’re making history together. Thanks for taking this journey with me and helping to shape the framework for the next year and years to come. You will always be the sunshine in my life. Thank you. [Applause.]I’d like to thank everyone. And please join us tonight for the Silver and Gold Networking Dinner, where we will present a few remaining awards and be entertained by our colleagues at MLA’s first-ever talent show. And get a sneak-peek at next year’s meeting, when the 2019 National Program Committee presents the MLA ’19 invitation. This session is now closed. [The Silver and Gold Networking Dinner, sponsored by McGraw-Hill Education, was held on Tuesday, May 22, 2018, from 6:30 p.m.–10:00 p.m. The networking dinner was in a different format than in previous years and featured a talent show, which included a live band, singing, a sing-along, and poetry. The MLA ’19 Invitation to Chicago also took place and was hosted by James Dale Prince, AHIP, chair, 2019 National Program Committee, and executive director, Southeastern/Atlantic Region, National Network of Libraries of Medicine, University of Maryland–Baltimore; Mellanye J. Lackey, cochair, 2019 National Program Committee, and associate director, Education and Research, Spencer S. Eccles Health Sciences Library, University of Utah–Salt Lake City; Rosie Hanneke, AHIP, chair, 2019 Local Assistance Committee, and information services and liaison librarian, Library of the Health Sciences, University of Illinois–Chicago; and Debra Werner, cochair, 2019 Local Assistance Committee, and director, Library Research in Medical Education, John Crerar Library, University of Chicago, Chicago, IL. The Dental Section, recipient of the MLA Section Project of the Year Award, and the Mid-Atlantic Chapter of MLA, recipient of the Majors/MLA Chapter Project of the Year (sponsored by J.A. Majors), were recognized during the dinner.Journal of the Medical Library Association.Section programs were presented in 4 time slots: Sunday, May 20, 3:00 p.m.–4:25 p.m.; Monday, May 21, 10:30 a.m.–11:55 a.m., and 1:00 p.m.–2:25 p.m.; and Tuesday, May 22, 3:00 p.m.–4:25 p.m. Paper abstracts that were scheduled to be presented are available on the MLA ’18 website. The final version of the abstracts, reflecting only those presented at the meeting, is included as an online-only Journal of the Medical Library Association.Poster sessions were presented in 4 time slots: Sunday, May 20, 2:00 p.m.–2:55 p.m.; Monday, May 21, 2:30 p.m.–3:25 p.m.; and Tuesday, May 22, 1:00 p.m.–1:55 p.m., and 2:00 p.m.–2:55 p.m. Poster abstracts that were scheduled to be presented are available on the MLA ’18 meeting website. The actual posters are available online in the MLA ’18 meeting website. The final version of the abstracts, reflecting only those posters presented at the meeting, is included as an online-only On Thursday, May 17, the MLA Board of Directors met. The MLA Board of Directors and Credentialing Committee met on Friday, May 18. On Saturday, May 19, the following groups met: 2019 National Program Committee; 2019 program planners; Chapter Council; Communities Strategic Goal Task Force; Joint Section Council/Chapter Council; National Network of Libraries of Medicine (NNLM) Steering Committee; Nominating Committee; and Section Council.JMLA Editorial Board; Leadership Curriculum Committee; Metadata 2020: Join the Discussion to Help Improve the Quality of Metadata for Research; Midcontinental Chapter Meeting and Greet #1; Outreach and Marketing SIG Business Meeting; Research and Evidence-Based Practice Curriculum Committee; Research Section Research Award Judging; Research4Life Grants Workshop Planning Session; Resource Sharing SIG Business Meeting; and Systematic Reviews SIG Business Meeting. Exhibitor meetings included: Lunch & Learn: AAAS/Science: The Blurred Line between Fact and Fiction; Medical Librarian Lunch and Learn: EBSCO Health; Cell Press & The Lancet Lunch & Learn: Best Practices in Publishing and Reproducibility; Supporting Institutional Research and Raising the Profile of the Library; and The R2 Digital Library as a Health Sciences eBook Database.On Sunday, May 20, the following groups, sections, and SIGs met: AAHSL Future Leadership Committee; AAHSL Leadership Fellows Program; AAHSL New and Developing Libraries Committee; Ad Hoc Committee to Review Core Clinical Journals; African American Medical Library Alliance SIG Business Meeting; chapter treasurers orientation meeting; Collection Development Section Business Meeting; Consumer and Patient Health Information Section (CAPHIS) Business Meeting and Executive Committee Meeting; Data SIG Business Meeting; Education Steering Committee; Educational Media and Technologies Section (EMTS) Business Meeting #1; Fellows of MLA; Health Disparities SIG Lunch; International Cooperation Section Business Meeting; Interprofessional Education SIG Business Meeting; On Monday, May 21, the following groups, sections, and SIGs met: 2020 National Program Committee; AAHSL Research Services Committee; Around the World: Global Librarians’ Experiences; Awards Endowment Task Force Meeting; Awards Committee; Books Panel; Cancer Librarians Section Business Meeting; Clinical Librarians and Evidence-Based Healthcare SIG Business Meeting; Complementary and Alternative Medicine SIG Business Meeting; Data Catalog Collaboration Information Session; Dental Section Business Meeting; Department of Veterans Affairs Librarians SIG Business Meeting #2; EMTS Business Meeting #2; Gaming in Adult Learning SIG Business Meeting; Government Relations Committee; Health Information Professionalism Committee; History of the Health Sciences Section Business Meeting; Hospital Libraries Section (HLS) Executive Board Meeting and Business Meeting and Social; Information Services Curriculum Committee; Instruction and Instructional Design Committee; Latino SIG Business Meeting; LGBQT Health Sciences Librarians SIG Business Meeting; Leadership Curriculum Committee; Libraries in Curriculum SIG Business Meeting; Medical Humanities SIG Business Meeting; Medical Informatics Section Business Meeting; Medical Libraries: Starting from Scratch; MLA Research Training Institute; Molecular Biology and Genomics SIG Business Meeting; New York-New Jersey Chapter Board Meeting; Nursing and Allied Health Resources Section (NAHRS) Business Meeting and Executive Board; Osteopathic Libraries SIG Business Meeting; Pacific Northwest Chapter Business Meeting; Pediatric Librarians SIG Business Meeting; Pharmacy and Drug Information (PDI) Section Business Meeting; Professional Recruitment and Retention Committee; Public Health/Health Administration Section Business Meeting; Public Services Section Business Meeting; Scholarly Communications Committee; Solo Librarians SIG Business Meeting; Technical Services Section Business Meeting; Transitional Sciences Collaboration SIG Business Meeting; Veterinary Medical Libraries Section Business Meeting; and Vision Section SIG Business Meeting. Exhibitor meetings included: Lunch & Learn: How to Conduct Systematic Reviews the JBI Way; and How to Provide a World-Class Systematic Review Service Using Covidence.On Tuesday, May 22, the following groups, sections, and SIGs met: AAHSL Program and Education Committee; Bylaws Committee; Diversity and Inclusion Task Force; education committee chairs joint meeting; Federal Libraries Section Business Meeting; Health Association and Corporate Libraries Section (HACLS) Business Meeting; Information Literacy in Medical Education (ILME) SIG Business Meeting; Information Management Curriculum Committee; Institutional Animal Care and Use SIG Open Discussion; Joint 2018 and 2019 Contributed Content Work Group; Leadership and Management Section Business Meeting; Joseph Leiter NLM/MLA Lectureship Committee; Librarians without Borders® Committee; Medical Library Education Section (MLES) Business Meeting; Medical Library Group of Northern California and Nevada Business Meeting; Medical Library Group of Southern California and Arizona Business Meeting; Membership Committee; Midcontinental Chapter Meeting and Greet #2; MLA community managers and webmasters; MLA News Editorial Board; Research Section Business Meeting; Rising Stars presentations; Rising Stars program; section treasurers orientation; Social Justice Section Business Meeting; Southern Chapter Executive Committee; Systematic Reviews SIG Informal Meeting; and Technical Services Section Social. Exhibitor meetings included: Lunch & Learn: Elsevier Luncheon for Medical Librarians: Collaboration for Innovation.On Wednesday, May 23, the following groups, sections, and SIGs met: Community Strategic Goal Task Force Meeting 2; Education Annual Programming Committee (EAPC); Grants and Scholarships Committee; and Oral History Committee.Three open forums were held on Sunday, May 20, from 4:30 p.m.–5:25 p.m.:MLA Communities Strategic GoalMLA Diversity and Inclusion Strategic GoalMLA InSight Initiative Summit 1 OutcomesThe National Library of Medicine (NLM) Update took place on Tuesday, May 22, 11:00 a.m.–11:55 a.m. Joyce E. B. Backus, associate director for library operations, began the session by introducing herself, Patricia F. Brennan, director of NLM, and Amanda J. Wilson, head, National Network Coordinating Office, National Network of Libraries of Medicine (NNLM), all of whom participated in the update.Dr. Brennan presented an explanation of the NLM Strategic Plan, “A Platform for Biomedical Discovery and Data-Powered Health 2017–2027.” The three pillars  were designed to target the future: (1) accelerate discovery and advance health through data-driven research; (2) reach more people through enhancement, dissemination, and engagement; and (3) build a workforce for data-driven research and health. In discussing the budget, Dr. Brennan said that NLM has received $22,000,000 for new investments in data science, accelerated training for librarians, and platform stabilization. She noted key accomplishments since February 2018.Ms. Backus reported on strategic planning activities and outcomes. She discussed MEDLINE 2022, a 5-year plan to do a behind-the-scenes modernization of MEDLINE and more efficient delivery of information on TOXNET. She introduced PubMed Labs and PubOne that launched in October 2017 and is a test site to try new features for PubMed 2.0, which will be released in December 2018. The NLM website has been refreshed: the PubMed Health Portal will be going away, but PubMed and Bookshelf will still have systematic review and drug information. MedlinePlus now includes Lab Test information. Ms. Backus mentioned several other NLM activities including the DeBakey Fellowship, rare book loans, visiting library and information science students, and NLM associate fellows.JAMA article on the history of NNLM from 1985–2015.Ms. Wilson noted NNLM year three activities and illustrated an organizational chart of NNLM. She highlighted projects in health literacy, hurricane relief, funding for classes, and the Wikipedia edit-a-thon. She showed videos of three examples of NNLM activities: University of Arizona, St. Paul, MN, and University of Pittsburgh Medical Center (UPMC). The All of Us public library initiative was also mentioned. Ms. Wilson showed a slide of the The remainder of the session was devoted to questions and answers.The Legislative Update was held on Tuesday, May 22, from 1:00 p.m.–1:55 p.m. Cristina Pope, AHIP, chair, MLA Governmental, Relations Committee, and director, Health Sciences Library, State University of New York (SUNY) Upstate Medical, University–Syracuse, moderated the session. Dina Paltoo, interim assistant director for policy development at NLM, presented information on the following: an overview of funding, functions of NLM, NLM’s most heavily used databases, statistics on PubMed Central, statistics on biomedical informatics and data science research, legislation and NLM, and bills and government activities that most affect NLM.Welcome Reception and Opening of the Hall of Exhibits, 5:00 p.m.–7:30 p.m.MLA New Members/First-Time Attendees Program and Breakfast, 7:00 a.m.–8:55 a.m.Yoga Class, 7:30 a.m.–8:30 a.m.Library School Reunion Tea, 2:00 p.m.–2:55 p.m.Clinical Librarianship Happy Hour, 5:30 p.m.–7:00 p.m.International Visitors Reception, 6:00 p.m.–7:00 p.m.Academy of Health Information Professionals Q&A Session, 2:30 p.m.–3:25 p.m.Diversity and Inclusion Task Force Fish Bowl, 5:00 p.m.–6:25 p.m.Public Librarian Welcome Breakfast and Speed-Networking Event, 7:00 a.m.–8:55 a.m.Public Librarians Symposium, Overview and Sessions 1 & 2, 9:00 a.m.–10:25 a.m.Public Librarians Symposium, Morning Concurrent Sessions 1 & 2, 11:00 a.m.–11:55 a.m.Public Librarians Symposium, Afternoon Concurrent Sessions 1 & 2, 1:00 p.m.–1:55 p.m.MLA Book Authors and Prospective Authors Gathering, 2:00 p.m.–2:55 p.m.Public Librarians Symposium, Health Literacy Heroes Sessions 1 & 2, 4:30 p.m.–5:25 p.m.Silver and Gold Networking Dinner, 6:30 p.m.–10:00 p.m.Exhibitors held Sunrise Seminars to provide information and to introduce new products and services. The following seminars were held:Artificial Intelligence (AI) in Health Care: From Adoption to DisruptionCochrane “Inside/Outside”: Update from Carol LefebvreEmbase Seminar: Librarian Roles in Teaching Evidence-Based MedicineThe Power of Single Sign-On and the Benefits to AllAmerican Psychological AssociationSpringer Nature Competitive Intelligence: Research Trends in Health CareThree Trends That Eclipse Point-of-Care ToolsTen Technology Showcases were held throughout Sunday, Monday, and Tuesday:Automating the Systematic Review Process: An Overview of DistillerSR’s New Productivity EnhancementsCase Files: Teaching Case CollectionCovering Your Nursing Bases: Research, Decision Support, and CompetenciesSupporting Your Interdisciplinary Care Dream TeamGetting Beyond the Impact Factor: Using Bibliometrics for Research Evaluation at the NIH LibraryTaking Medical Research to the Next Level: 72,987,390 Searches Can’t Be WrongThe Ever-Evolving World of Medical E-BooksFrom Data Standards to DermExpert: The Story of How an Image Collection Learned to ThinkLooking to the Future with EndNoteTop Questions Medical Libraries Ask OpenAthensThe 2017/2018 Education Annual Programming Committee offered the following courses to 236 attendees on May 18 and 19, 2018.Instructors: Julie Glanville, MCLIP, associate director, York Health Economics Consortium, University of York, York, United Kingdom, and Carol Lefebvre, HonFCLIP, independent information consultant, Lefebvre Associates, Oxford, United KingdomCE100 Advanced Searching Techniques and Advanced Strategy Design, Instructors: Karen Gutzman, impact and evaluation librarian, and Patricia L. Smith, impact and dissemination librarian, Galter Health Sciences Library, Feinberg School of Medicine, Northwestern University, Chicago, ILCE200 Dissemination in Action: Communicating Research in a Digital World, Instructors: Sarah Young, senior librarian, Mellon Institute Library, Carnegie Mellon University, Pittsburgh, PA; Jin Wu, emerging technologies librarian, Norris Medical Library, University of Southern California–Los Angeles; and Ayaba Logan, research and education informationist and assistant professor, Medical Libraries, University of South Carolina–CharlestonCE502 Statistics 101: A Primer in Statistical Methods for Health Sciences Librarians, Instructors: Gwen Wilson, health sciences librarian, Mabee Library, Washburn University, Topeka, KS, and Kristen DeSanto, AHIP, clinical librarian, Health Sciences Library, Anschutz Medical Campus, University of Colorado–AuroraCE600 Building Partnerships with Faculty, Clinicians, and Other Stakeholders, Instructors: Erin Eldermire, head, Flower-Sprecher Veterinary Library, Cornell University Library, Ithaca, NY; Sarah Young, senior librarian, Mellon Institute Library, Carnegie Mellon University, Pittsburgh, PA; and Lenny Rhine, FMLA, coordinator, E-Library Training Initiative, Librarians without Borders®/MLA, Gainesville, FLCE101 Performing Systematic Reviews in Resource-Limited Settings, Instructors: Julie Glanville, MCLIP, associate director, York Health Economics Consortium, University of York, York, United Kingdom, and Carol Lefebvre, HonFCLIP, independent information consultant, Lefebvre Associates, Oxford, United KingdomCE102 Trials without Tribulations: Identifying Clinical Trials for Systematic Reviews and Other Clinical and Research Questions, Instructors: Wichor M. Bramer, biomedical information specialist, Medical Library, Erasmus University Medical Center, Rotterdam, the Netherlands, and Melissa L. Rethlefsen, AHIP, deputy director, Spencer S. Eccles Health Sciences Library, University of Utah–Salt Lake CityCE103 Effectiveness and Efficiency in Exhaustive Searches, Instructors: Rachel Pinotti, AHIP, assistant library director, Education and Research Services, Levy Library, Icahn School of Medicine at Mount Sinai, New York, NY; Antonio P. DeRosa, AHIP, oncology consumer health librarian and assistant librarian faculty, Samuel J. Wood Library and C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, NY; and Diana Delgado, AHIP, associate director, User Support, Research and Education, Samuel J. Wood Library and C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, NYCE104 Upping Your Reference Game: Technologies and Strategies for Value-Added Reference Services, Instructor: Michele Malloy, research librarian, Congressional Research Service, Library of Congress, Washington, DCCE105 Health Policy Research: Navigating Governmental and Legislative Sources, Instructors: Julia M. Esparza, AHIP, head, User Education and Outreach Services; Montie’ L. Dobbins, head, User Access Services/Circulation; and David C. Duggar, AHIP, head, Library Liaison Program; Health Sciences Library, Louisiana State University (LSU) Health–Shreveport; and Alexandria (Lexi) Brackett, AHIP, clinical support librarian, Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CTCE300 Not Just Numbers: Teaching Students to Think Using Practical Curriculum Exercises, Instructor: Jessica Sender, librarian, College of Nursing, Michigan State University–East LansingCE301 Innovations in Nursing Information Literacy: New Technologies, Approaches, and Ideas, Instructors: Andy Hickner, web services librarian, Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, and Susanna Galbraith, virtual services librarian, Health Sciences Library, McMaster University, Hamilton, ON, CanadaCE302 Peeking Under the Hood: Understanding, Assessing, and Improving Your Library’s Website and LibGuides, Instructors: Jamie Conklin, research and education librarian, and Megan von Isenburg, AHIP, associate dean, Library Services and Archives, Medical Center Library & Archives, Duke University, Durham, NCCE303 Evidence-Based Teaching: Finding and Applying the Best Evidence to Instruction, Instructors: Heidi Heilemann, AHIP, associate dean and knowledge management director, Lane Medical Library and Knowledge Management Center, Stanford University, Stanford, CA; M.J. Tooey, AHIP, FMLA, associate vice president, Academic Affairs, and executive director, Health Sciences and Human Services Library, University of Maryland–Baltimore; and Gabriel Rios, director, Ruth Lilly Medical Library, Indiana University–IndianapolisCE400 Do You Want to Be a Library Director? Knowledge, Skills, and Career Paths for Library Leaders, Instructor: Erinn Aspinall, AHIP, strategic initiatives librarian and communications coordinator, Bio-Medical Library, Health Sciences Libraries, University of Minnesota–MinneapolisCE401 Digital Storytelling: Communication for Greater Impact, Instructor: Ayaba Logan, research and education informationist and assistant professor, Medical Libraries, Medical University of South Carolina–CharlestonCE500 What Did You Hear? Qualitative Data Analysis, Instructors: Marci Brandenburg, bioinformationist, and Jean Song, assistant director, Academic and Clinical Engagement, Taubman Health Sciences Library, University of Michigan–Ann ArborCE501 Introduction to Visualization Principles, Instructor: Lisa Federer, AHIP, research data informationist, NIH Library, National Institutes of Health, Bethesda, MDCE503 Introduction to Data Analysis and Visualization with R, Instructors: David A. Nolfi, AHIP, health sciences librarian and library assessment coordinator, Gumberg Library, Duquesne University, Pittsburgh, PA, and Carolyn Schubert, interim director, Research and Education Services, and health sciences and nursing librarian, Carrier Library, James Madison University, Harrisonburg, VACE601 Learning to Liaise with Health Professions, The online itinerary planner (sponsored by Wolters Kluwer) allowed attendees to peruse programs and events online. Complimentary WiFi was available throughout the Hyatt Regency Atlanta courtesy of The JAMA Network. Live streaming was available on Twitter using the hashtag #MLANET18, and volunteer bloggers, the Local Assistance Committee, and the 2018 National Program Committee contributed to the official meeting blog with meeting tips, announcements, and more. For those seeking new jobs and prospective employers, the Job Placement Center was open from Saturday through Tuesday, and the MLA Resume Clinic was available Saturday through Monday. The Hall of Exhibits was open Saturday evening through Monday.AppendixClick here for additional data file.AppendixClick here for additional data file.


Transcranial magnetic stimulation (TMS) has been evaluated as an effective treatment option for patients with major depressive disorder. However, there are limited studies that have evaluated the efficacy of TMS for other neuropsychiatric disorders such as anxiety and trauma‐related disorders. We reviewed the literature that has evaluated TMS as a treatment for anxiety and trauma‐related disorders.n = 520) evaluating TMS in anxiety and trauma‐related disorders were screened and a small subset of these that met the eligibility criteria (n = 17) were included in the systematic review, of which nine evaluated TMS in posttraumatic stress disorder (PTSD), four in generalized anxiety disorder (GAD), two in specific phobia (SP), and two in panic disorder (PD). The meta‐analysis was performed with PTSD and GAD since PD and SP had an insufficient number of studies and sample sizes.We searched for articles published up to December 2017 in Embase, Medline, and ISI Web of Science databases, following the Preferred Items for Reporting of Systematic Reviews and Meta‐Analyses (PRISMA) statement. Articles  and GAD , including applying high frequency over the right dorsolateral prefrontal cortex. Since few studies have evaluated TMS for SP and PD, few conclusions can be drawn.Our meta‐analysis suggests that TMS may be an effective treatment for GAD and PTSD. We reviewed TMS as a treatment for anxiety disorders and PTSD.TMS presented large effect sizes as a treatment for PTSD and GAD.Follow‐up studies in GAD showed improvement of patients after TMS.Future studies should evaluate maintenance treatment.1Transcranial magnetic stimulation (TMS) is a safe, effective, noninvasive, and nonconvulsive neuromodulation therapy cleared by the U.S. Food and Drug Administration (FDA) for the treatment of the major depressive disorder (MDD) since 2008  until it reached the neurons of the cortex. At this level, the magnetic field converts back into a (secondary) electrical current able to depolarize neurons and force an action potential, which will then travel from synapse to synapse across an entire functional circuit of interest  following the recommendations of the Preferred Items for Reporting of Systematic Reviews and Meta‐Analyses (PRISMA) statement , because this is the minimum number of sessions to induce plasticity and improve symptoms for long term, while in SP a short‐term effect may be useful since the symptoms are more punctual , response and remission rates, and period of follow‐up. We contacted authors for additional data whenever necessary and we greatly appreciate the contributions of Dr. Zangen, Osuch, and Watts . In case of moderate or high heterogeneity (I2> 50%), a sensitivity analysis was done to determine the impact of each study on the results and a meta‐regression was performed to evaluate the influence of each TMS parameter at a time. For studies without the SD of the total score of the primary outcome, the largest similar SD found in other studies was repeated, according to the Cochrane Handbook for Systematic Review . Of those, 123 were duplicate references, and 37 were not in the English language. The remaining 483 references underwent a title and abstract analysis after which 419 were excluded. Finally, 64 articles were recovered for full‐text reading. After this process, only 17 articles met the inclusion criteria of articles that assessed TMS as a treatment for anxiety disorders or PTSD  ; therefore, the difference between studies is by chance. Possible causes of publication bias were tested with the funnel plot . Table The overall effect size was −2.06 , widely favoring active rTMS treatment. There was low heterogeneity . The funnel plot is symmetric , suggesting that publication bias is unlikely. The reported dropouts and the amount of these that are due to side effects are in Tables The treatment of PTSD with TMS is the most studied among the conditions of interest. Nine studies were included in this meta‐analysis   or sham (n = 13) rTMS. They applied 1 Hz, at 110% RMT, and 1,800 pulses/session, over the rDLPFC, for 4 weeks. After the last week of treatment, patients in active rTMS had a significant improvement in their PD but not in their MDD. This study was followed by four additional weeks of an open‐label treatment in which patients in the sham group could undergo active treatment and patients in the active group could receive additional treatment. After this second phase, patients continued to improve from PD and improved from MDD. Subsequently, at a 6‐month follow‐up, patients showed sustained improvement of both disorders  aim that are informative in the context of this review. These studies evaluated rTMS or excitatory intermittent theta burst stimulation (iTBS) as a treatment for SP  or sham (n = 19) rTMS applied before a virtual reality exposure to heights in two groups of individuals diagnosed with acrophobia. The protocol consisted of two active sessions of 20 min of rTMS with 10 Hz, at 100% RMT, 4 s on and 26 s off, with 1560 pulses per session, and the sessions were 1 week apart. At the end, anxiety  and avoidance ratings  decreased in the active group  in fear extinction  included in this meta‐analysis presented adverse events , a number of trials have been published particularly for GAD and PTSD. Our meta‐analysis concludes an overall positive therapeutic effect of TMS for these two conditions. These results suggest (but do not prove) an advantage of right over lDLPFC stimulation, and the possible therapeutic advantage of high‐frequency stimulation to the rDLPFC. Based on the studies that reported side effects, TMS demonstrated to be safe and well tolerated in the treatment of anxiety disorders and PTSD but reports of side effects were inconsistent. In summary, the result of this meta‐analysis confirms the therapeutic potential and safety of TMS for GAD and PTSD and generates some hypotheses for upcoming prospective, larger, and appropriately powered randomized controlled trials to confirm these results.. AAN reports the following disclosures: Consultant ‐ Abbott Laboratories, Alkermes, American Psychiatric Association, Appliance Computing Inc. (Mindsite), Basliea, Brain Cells, Inc., Brandeis University, Bristol Myers Squibb, Clintara, Corcept, Dey Pharmaceuticals, Dainippon Sumitomo (now Sunovion), Eli Lilly and Company, EpiQ, L.P./Mylan Inc., Forest, Genaissance, Genentech, GlaxoSmithKline, Healthcare Global Village, Hoffman LaRoche, Infomedic, Intra‐Cellular Therapies, Lundbeck, Janssen Pharmaceutica, Jazz Pharmaceuticals, Medavante, Merck, Methylation Sciences, NeuroRx, Naurex, Novartis, PamLabs, Parexel, Pfizer, PGx Health, Otsuka, Ridge Diagnostics Shire, Schering‐Plough, Somerset, Sunovion, Takeda Pharmaceuticals, Targacept, and Teva; consulted through the MGH Clinical Trials Network and Institute (CTNI) for Astra Zeneca, Brain Cells, Inc, Dianippon Sumitomo/Sepracor, Johnson and Johnson, Labopharm, Merck, Methylation Science, Novartis, PGx Health, Shire, Schering‐Plough, Targacept and Takeda/Lundbeck Pharmaceuticals, NeuroRx Pharma, Pfizer, Physician's Postgraduate Press, Inc. Grants/Research support ‐ American Foundation for Suicide Prevention, AHRQ, Brain and Behavior Research Foundation, Bristol‐Myers Squibb, Cederroth, Cephalon, Cyberonics, Elan, Eli Lilly & Company, Forest, GlaxoSmithKline, Intra‐Cellular Therapies, Janssen Pharmaceuticals, Lichtwer Pharma, Marriott Foundation, Mylan, NIMH, PamLabs, Patient Centered Outcomes Research Institute (PCORI), Pfizer Pharmaceuticals, Shire, Stanley Foundation, Takeda/Lundbeck, and Wyeth‐Ayerst. Honoraria ‐ Belvoir Publishing, University of Texas Southwestern Dallas, Brandeis University, Bristol‐Myers Squibb, Hillside Hospital, American Drug Utilization Review, American Society for Clinical Psychopharmacology, Baystate Medical Center, Columbia University, CRICO, Dartmouth Medical School, Health New England, Harold Grinspoon Charitable Foundation, IMEDEX, International Society for Bipolar Disorder, Israel Society for Biological Psychiatry, Johns Hopkins University, MJ Consulting, New York State, Medscape, MBL Publishing, MGH Psychiatry Academy, National Association of Continuing Education, Physicians Postgraduate Press, SUNY Buffalo, University of Wisconsin, University of Pisa, University of Michigan, University of Miami, University of Wisconsin at Madison, APSARD, ISBD, SciMed, Slack Publishing and Wolters Klower Publishing, ASCP, NCDEU, Rush Medical College, Yale University School of Medicine, NNDC, Nova Southeastern University, NAMI, Institute of Medicine, CME Institute, ISCTM, World Congress on Brain Behavior and Emotion, Congress of the Hellenic Society for Basic and Clinical Pharmacology, ADAA. Stock ‐ Appliance Computing, Inc. (MindSite); Brain Cells, Inc., Medavante. Copyrights ‐ Clinical Positive Affect Scale and the MGH Structured Clinical Interview for the Montgomery Asberg Depression Scale exclusively licensed to the MGH Clinical Trials Network and Institute (CTNI). Speaker Bureaus ‐ none since 2003. JAC is a scientific advisor for Apex Neuroscience. GK has received research support from Astra‐Zeneca, Bristol‐Myers Squibb Company, Cephalon, Elan Pharmaceuticals, Eli Lilly & Company, Forest Pharmaceuticals Inc., GlaxoSmithkline, Sanofi/Synthelabo, Sepracor Inc., Pfizer Inc, UCB Pharma, and Wyeth‐Ayerst Laboratories, Agency for Healthcare Research and Quality (AHRQ) Grant R01 HS019371‐01, and Takeda Pharmaceuticals. He has been an advisor or consultant for Astra‐Zeneca, Cephalon, Eli Lilly & Company, Forest Pharmaceuticals Inc., GlaxoSmithkline, Janssen Pharmaceutica, Pfizer Inc, Sepracor Inc., UCB Pharma, and Wyeth‐Ayerst Laboratories. GK has been a speaker for Astra‐Zeneca, Forest Pharmaceuticals Inc., GlaxoSmithkline, Sepracor Inc., and Wyeth‐Ayerst Laboratories. The other authors have no conflicts of interest to declare.AKG receives research support from NIMH


GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388: 1459–1544—2016: In this Article, Tea Lallukka, Anoushka Millear, and Amanda Pain should have been listed as authors. The affiliation details for Monica Cortinovis and Giorgia Giussani have been updated. An affiliation and funding statement have been added for Simon I Hay. These corrections have been made to the online version as of Jan 5, 2017.


Scientific Reports 10.1038/s41598-019-42919-y, published online 01 May 2019Correction to: In the original version of this manuscript, the incorrect isolate ID was provided for NCHW8.In addition, the Article contained an error in Affiliation 6, which was incorrectly given as ‘Department of Bacteria, Parasites and fungi, Staten Serum institut, copenhagen, Denmark’. The correct affiliation is listed below:Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, DenmarkThese errors have now been corrected in the HTML and PDF versions of the article.


Background: The number of papers published by an institution is acknowledged as an easy-to-understand research outcome. However, the quantity as well as the quality of research papers needs to be assessed.Methods: To determine the relation between the number of published papers and paper quality, a survey was conducted to assess publications focusing on interventional clinical trials reported by 11 core clinical research hospitals. A score was calculated for each paper using Système d’interrogation, de gestionet d’analyse des publications scientifiques scoring system, allowing for a clinical paper quality assessment independent of the field. Paper quality was defined as the relative Journal impact factor (IF) total score/number of papers.Results: We surveyed 580 clinical trial papers. For each of the 11 medical institutions (a–k), respectively, the following was found: number of published papers: a:66, b:64, c:61, d:56, e:54, f:51, g:46, h:46, i:46, j:45, k:45 ; total Journal IF: a:204, b:252, c:207, d:225, e:257, f:164, g:216, h:190, i:156, j:179, k:219 ; relative Journal IF total score: a:244, b:272, c:260, d:299, e:268, f:215, g:225, h:208, i:189, j:223, k:218 ; and paper quality : a:3.70, b:4.25, c:4.26, d:5.34, e:4.96, f:4.22, g:4.89, h:4.52, i:4.11, j:4.96, k:4.84 . Additionally, no significant relation was found between the number of published papers and paper quality .Conclusions: The number of published papers does not correspond to paper quality. When assessing an institution’s ability to perform clinical research, an assessment of paper quality should be included along with the number of published papers. Système d’interrogation, de gestionet d’analyse des publications scientifiques , is used to calculate a score that objectively assesses paper quality  of the journal in which the article has been published . However quality , allowinFor this study, 580 clinical trial papers were surveyed to investigate the relation between number of papers and paper quality . Clinical trial papers were retrieved from 11 core clinical research hospitals in Japan.Based on data published on the website of the Ministry of Health, Labour and Welfare, a descriptive research was conducted to compare the quantity and quality of clinical trial papers published by 11 core clinical research hospitals. A relative Journal IF score, based on the SIGAPS scoring system, was used to assess paper quality.In Japan, core clinical research hospitals are appointed by the Medical Care Act. They play a central role in physician-led clinical trials and in clinical research developed according to international standards toward the development of innovative pharmaceuticals and medical instruments in Japan. These hospitals support clinical research developed in other medical institutions and play a key role in optimizing next-generation healthcare by enhancing the quality of clinical research in those medical institutions where joint research efforts are conducted.The Ministry of Health, Labour and Welfare grants approval for core clinical research hospitals , which aTo meet former clinical research performance requirements, core hospitals must have submitted a minimum of 45 clinical trial papers published over the last three years. All papers were required to be published in PubMed. Requirements for approval of hospitals as core clinical research institutions, as determined by the Ministry of Health, Labour and Welfare, only include the development of interventional clinical trials, excluding observational studies.For study purposes, all clinical trial papers submitted until November 2018 by 11 core hospitals were extracted from the Ministry of Health, Labour and Welfare website and examined. Additionally, a list of clinical trial publications from each study hospital was retrieved from a 2017 business report of core clinical research hospitals published by the Ministry of Health, Labour and Welfare .Using PubMed “JournalTitle,” “MedAbbr,” and “IsoAbbr,” search strings, both printed and online International Standard Serial Number information was obtained by comparing journals in which papers listed in the business report were published. If a match between PubMed records and journal list content could not be found, a visual check was conducted whenever appropriate.Relative Journal IF score was calculated based on the SIGAPS scoring system. Research fields of each clinical trial papers were initially categorized based on the Web of Science Category. A Journal IF percentile was then calculated for each field, and both a rank and a score  were attributed to each journal based on that percentile Table 1.For journals with multiple IF percentiles, the highest value was selected. Additionally, paper quality was defined as relative Journal IF total score/number of papers.SIGAPS components include the journal’s rank and the author’s rank, including first or last author (4 points), second or second-to-last author (3 points), third author (2 points), or any other contributing author (1 point) with a weighting factor. However, to approve a clinical research hospital, the Ministry of Health, Labour and Welfare requires that the first author of a clinical publication belongs to the considered institution. For this reason, in this study the relative Journal IF score was calculated based on only the journal’s rank.The correlation between paper quantity and quality was estimated through the Spearman’s correlation coefficient. Aggregation and analysis of all data was performed using SAS ver. 9.4 .Overall, 580 clinical trial publications from the last three years were surveyed. The number of published papers, total Journal IF, relative Journal IF total score, and paper quality  for each of the 11 medical institutions investigated are shown in A comparison between the number of published papers and paper quality is shown in We performed additional analyses with data excluding 44 protocol papers. The following was found: number of published papers: a:41, b:56, c:61, d:54, e:54, f:51, g:45, h:45, i:40, j:44, k:45 ; total Journal IF: a:166, b:221, c:207, d:218, e:257, f:164, g:213, h:188, i:147, j:175, k:219 ; relative Journal IF total score: a:180, b:243, c:260, d:289, e:268, f:215, g:221, h:205, i:172, j:219, k:218 ; and paper quality : a:4.39, b:4.34, c:4.26, d:5.35, e:4.96, f:4.22, g:4.91, h:4.56, i:4.30, j:4.98, k:4.84 . No significant relation was also found between the number of published papers and paper quality .In this study, 580 clinical trial papers reported by 11 core clinical research hospitals in Japan were surveyed to examine the relation between quantity and quality of publications. Results showed no significant relation between the number of papers published by a hospital and the quality of those papers. Therefore, an evaluation of both the number and quality of published papers should be performed when assessing an institution’s competence to execute clinical research based on their scientific publications.This study employed a quality assessment metric indicator  calculated based on the SIGAPS scoring system. SIGAPS was developed in 2002 at the French University Hospital, Lille (CHU) . The SIGIn this study, the only paper quality assessment measure used was the relative Journal IF score. However, other metrics must be considered. The citation index is one such candidate . HoweverWhen assessing the quality of medical publications, it is also necessary to account for their contribution to the development of treatment guidelines. Medical treatment guidelines are developed by field specialists, and they provide the latest evidence-based data on medical practices and procedures in the clinical setting. Areas covered ranged from disease pathophysiology to prevention, diagnosis, treatment, and rehabilitation, and guidelines in each of these areas contribute to improve quality standards of medical treatment. Medical treatment guidelines are important contributions to healthcare, and publications focusing them should be considered as high-quality, regardless of the journal’s IF or citation index.The method for calculating relative Journal IF based on the SIGAPS scoring system that was developed in France is clear and technically acceptable in any country other than France, as described in the Methods section. However, there are issues regarding Journal IF that still need to be solved. One challenge is the adequate assessment of negative studies. For example, clinical researchers tend not to publish negative studies with small sample sizes. This could cause publication bias. Since negative studies with small sample sizes may have a very high social significance, there is a need to create a mechanism to appropriately incorporate the value of negative studies with small sample sizes in Journal IF.Although the focus of this study was paper quality assessment, it is equally important to develop objective metric indicators for quality assessment of clinical research itself. Months or years can go between completion of clinical studies and publication of their results. Therefore, in absence of a metric indicator for paper quality assessment, quality assessment of the ongoing or recently completed clinical study is not possible. Developing metric indicators to assess the quality of clinical research, and not only the quality of resulting publications, is therefore an unmet and urgent need. As the next step, an index should be added that can objectively evaluate the quality of the research process, including the number of patients enrolled, speed of enrollment, rate of satisfaction with enrollment, number of protocol deviations, and number of protocol amendments.The present study has several limitations, including undeniable social issues. The first limitation is the method used to calculate the relative Journal IF score. This method attributes a score by categorizing a paper based on the percentiles for its field, and a concern exists that the maximum and minimum Journal IF in the same percentile may be treated as the same score.The second limitation relates to policy differences for assessment of track records of research institutions, which constitutes an undeniable social issue. When assessing faculty track records, some research institutions may prioritize paper quality over the number of published papers, others may take the opposite approach, and others may even prioritize citations instead. Overcoming these inconsistencies will require the development of metric indicators combining number of papers and relative Journal IF scores with citation indexes or h-indexes in a well-balanced fashion.The third limitation is the impact of research fields considered, at certain times, as “fashionable.” This also constitutes an indisputable social issue. At different time periods, research in popular fields may register great advances, and government agencies and foundations tend to apply their budgets accordingly. Research institutions that can adapt to such trends are likely to experience an increase, both in the number of published papers, as in paper quality. Counteracting this trend-driven impact is difficult. For example, in the field of rare and incurable diseases, the Government of Japan’s “Act on Medical Care for Patients with Intractable Diseases,” passed on May 23, 2014, promoted a reform and the establishment of a sustainable social insurance system. The law went into effect on January 1, 2015, using consumption taxes to create funding for healthcare subsidies and a stable healthcare subsidy system for patients with rare and incurable diseases . ResearcThe fourth limitation is management of protocol papers. Because the approval requirements for core clinical research hospitals include protocol papers, a total of 44 protocol papers have been included in this study . Although these have several benefits, such as deterring publishing bias, preventing similar research, and giving hope to patients regarding the possibility of new or innovative treatments, protocol papers are published at the start of research, prior to result generation. Therefore, their quality should be evaluated separately from that of result-generating publications. We performed additional analyses with the data, excluding the 44 protocol papers. The results revealed a trend similar to that of the overall results. However, an analysis of protocol publications alone was not performed this time because of the limited number available, which was 44.The fifth limitation is the evaluation of open access journals, which are known to have a higher citation impact than closed journals . Future Finally, the relation between paper quantity and quality was only assessed for interventional clinical trials in this study. To address this issue, a subsequent study targeting both interventional and observational studies is currently being planned.This study revealed that the quantity of papers published by an institution does not necessarily correspond to their quality. When assessing an institution’s ability to execute clinical research, assessment of paper quality should be included alongside assessment of the number of published papers.ynishiza@juntendo.ac.jpThe datasets analyzed in this manuscript are not publicly available. Requests to access the datasets should be directed to Yuji Nishizaki, RU and YN designed this study in whole and drafted this manuscript. RU contributed to data collection. NaoY and SN contributed to statistical analysis. YH, SS, TO, SY, KM, NaoY, MN, KF, SN, YS, NatY, and PD provided advice on the interpretation of results. YN and HD provided a critical revision of the manuscript for intellectual content and gave the final approval for the submitted manuscript. All authors have read and approved the final manuscript.The study was supported by a grant from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP181k1903001 from April 1, 2018 to March 31, 2019.The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


This article presents the raw data in relation to the status of, and the distribution of, the 41 marine algal species occurring around and within the An Thoi coral reef strictly protected zone, Phu Quoc Marine Protected Area. The data, which were collected in May 2017, include the detailed description of the locations, the oceanographical conditions, and the photographs of the 41 marine algal species. For more insight, please see “Marine algal species and marine protected area management: A case study in Phu Quoc, Kien Giang, Vietnam” Huynh and Nguyen, 2019. A total


The data was obtained to present the environmental and occupational exposure to lead in Iranian populations based on the published articles. To acquire the data, online resources including Google Scholar, Magiran, SID, Iranmedex, PubMed, and Science Direct were searched and 104 articles were found out of which 70 that focused on the level of lead in blood, urine, milk, and hair of different Iranian populations were selected. Since the results of the studies were not homogenous, it was not possible to carry out a meta-analysis. The average blood lead level (BLL) among workers, ordinary people, patients with specific diseases, addicts, and pregnant women, women in labor, infants, and children are presented in this article. The average BLL was compared to the standards. Specifications TableValue of the data•The data provides information on the level of lead exposure among different Iranian groups, and is important for scientific community.•The data clarifies protective, managerial, and policy-making measures of the risks involved with lead exposure more than before.•The data can be useful as it collects all the available information about the blood lead level amount Iranians.12The data is based on the articles that were sporadically carried out on certain groups and different cities and published in domestic and foreign journals. The articles were selected from different databases including Google Scholar, Magiran, SID, Iranmedex, PubMed, and Science Direct. While searching the articles, keywords like lead, occupational exposure to lead, lead measuring, human lead contamination, BLL, blood lead level, lead poisoning, lead toxicity, lead exposure were used and their Persian equivalents in Persian websites. All articles published by March 20, 2014 were included. First, all articles on lead exposure carried out in Iran were collected. At this stage, all articles that contained the mentioned keywords in their title or abstract were included in the primary list. Afterwards, a checklist of necessary study information, including study location, study year, sample environment, sample size, and average blood lead level (BLL), was prepared for final evaluation. Searching and extracting of the data was independently carried out by one person. A total of 104 articles that were available by March 20, 2014 were examined. Out of the 104 articles, 70 that were referable were taken used workers, ordinary people, patients with specific diseases, addicts, and pregnant women, women in labor, infants, and children.


The authors wish to make the following corrections to this paper :The 5th author, Steven C. Katz was affiliated with the Department of Surgery, Boston University School of Medicine, Boston, MA 02118, USA. The authors would like to add the following 4th affiliation to Steven C. Katz: “Roger Williams Medical Center, Providence, RI 02908, USA” The authors would like to apologize for any inconvenience caused to the readers by these changes.


In the published article, there was an error in affiliation 9. Instead of “UF de Neurobiologie, Centre Biologie Pathologie du CHU-Lille, Lille, France,” it should be “Univ Lille, Inserm, UMRS 1172, LabEx DISTALZ, Lille, France.”Additionally, Stéphanie Bombois was not included as an author in the published article. The corrected Author Contributions Statement appears below.“ED, DG, AG, CB, BA, and SL performed measurements and collected data. J-SV performed statistical analysis. FP, LB, SS-M, A-SR, OH, and JE supervised the study. SB collected data revised the manuscript; Final approval of the version to be published; and is an Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.”The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Tctively) , and ranve for A ,7. As thve for A ,6,7, andve for A ,13,14,152NH-  moieties, which can participate in multiple interactions with metal ions, amino acid residues, DNA or RNA moieties present in various biomolecules acting as drug targets [Indeed, the sulfonamides constitute an important class of drugs, with many types of pharmacological agents possessing antibacterial , anti-ca targets ,28,29,30 targets ,24,25,26Molecules is in fact a nice example of this multitude of possible applications of the sulfonamides, with the wide range of targets to which they bind, diverse synthetic procedures and pharmacological applications, some of which highly innovative, for many representatives of this interesting class of pharmacologic agents. The first contribution is a nice review article [The following special issue of  article  from Sil article .Mycobacterium species, such as M. avium, M. kansassii, some of them showing remarkable activity [Considering the fact that the sulfonamides were the first antibacterials ,32, due activity .Burkholderia pseudomallei, and the inhibition of these enzymes with a range of more than 40 sulfonamides and sulfamates. Indeed, due to the relevant problem of drug resistance to commonly used antibiotics, the inhibition of CAs from pathogenic organisms started to be considered as an alternative, innovative approach for finding new such pharmacologic agents [The next three papers in the special issue ,38,39 dec agents .The next paper  presents2NH2) which incorporate a 1-benzhydrylpiperazine tail, connected to the sulfonamide scaffolf by means of β-alanyl or nipecotyl spacers was reported and investigated for the inhibition of CAs of human (h) origin, such as hCA I, II, IV and IX. Some of these isoforms are established drug targets, but many sulfonamide or sulfamide inhibitors show little selectivity when inhibiting them. Some of the new sulfamides reported in this paper did show some selective inhibitory profile, mainly against hCA I, which has been rationalized by using computational methods [In the paper by Berrino et al.  a new se methods .The next paper in the special issue  investigMarciniec et al.  present In the paper by Lin et al.  sulfadiaIn conclusion, the present special issue presents an interesting collection of high quality papers which underline the many potential applications of the simple, sulfonamide structural motif, a highly used, almost magic moiety in the tool kit of medicinal chemists.


Molecules. Two inadvertent errors were found from Table 2 footnotes section:The authors wish to make the following corrections to this paper published in Footnote k states that “k = Tripeptide containing Arg, Glu and Val; or Arg, Asp and Leu or Ile; or Gln, Gln and Lys or a tetrapeptide containing Ala, Ala, Asp and Lys; or Ala, Gln, Gly and Lys or a pentapeptide containing Ala, Ala, Gly, Gly and Lys”. However, it should be “k = Tripeptide containing Arg, Glu and Val; or Arg, Asp and Leu or Ile; or Gln, Gln and Lys or a tetrapeptide containing Ala, Ala, Asn and Lys; or Ala, Gln, Gly and Lys or a pentapeptide containing Ala, Ala, Gly, Gly and Lys”.Footnote n states that “n = Tripeptide containing Ala, Glu and Val; or Glu, Glu and Leu or Ile; or Pro, Thr and Thr; or Ala, Asp and Leu or Ile; or an acetylated tripeptide containing Gly, Ser and Leu and Ile; or Gly, Thr and Val; or the methyl ester of a tripeptide containing Ala, Asp and Val or Asp, Gly and Leu or Ile”. However, it should be “n = Tripeptide containing Ala, Glu and Val; or Glu, Gly and Leu or Ile; or Pro, Thr and Thr; or Ala, Asp and Leu or Ile; or an acetylated tripeptide containing Gly, Ser and Leu or Ile; or Gly, Thr and Val; or the methyl ester of a tripeptide containing Ala, Asp and Val or Asp, Gly and Leu or Ile”.These changes have no material impact on the conclusions of our paper. We apologize for any inconvenience to our readers.


An introduction to a series of essays honoring Erich Meyerhoff (1919–2015), AHIP, FMLA, who was active in and contributed to the Medical Library Association for generations. Journal of the Medical Library Association (JMLA), to catch a glimpse of him and understand why he is honored with a festschrift sponsored by the Fellows of the Medical Library Association (MLA).A few times in each generation, we count ourselves fortunate if we have had the opportunity to know an extraordinary individual. Such an individual was Erich Meyerhoff, AHIP, FMLA (1919–2015), who marked his time not simply by living a very long life, but by doing, creating, enabling, and inspiring those around him. He had a passion for his profession and the individuals who made up that profession. Those of us who were not fortunate to know him personally now have the opportunity, through the series of essays published in this issue of the JMLA, provided an overview of his career and, most notably, comments from his peers [Erich was active in and contributed to MLA for generations. His legacy is one of unparalleled support for and encouragement of MLA and its members. His obituary, published in is peers . DescripThe series of essays in this festschrift provides a snapshot of an extraordinary individual who exemplified professionalism and an abiding faith in social justice and the possibilities of what an organization such as MLA could achieve in the twentieth and twenty-first centuries. This festschrift is meant not only to honor Erich, but to provide an example of a professional life well lived for current and future members of MLA. His activities and accomplishments were recognized by MLA through the Marcia C. Noyes Award, the Janet Doe Lectureship, and MLA Fellowship, but there was much more to Erich than these important awards or his longevity.In their essay, “Erich Meyerhoff: A Man for All Medical Librarians,” Judith Messerle, AHIP, FMLA, and Lucretia W. McClure, AHIP, FMLA, provide a sketch of his life, education, career, and accomplishments, which spanned many significant developments in health sciences librarianship . They noUnion Catalog of Medical Periodicals and lasted as a resource center and service bureau from 1960 to 2003.Patricia E. Gallagher, AHIP, FMLA, traces the development of the Medical Library Center of New York in her essay, “Library Resource Sharing and the Medical Library Center of New York” . The cenElaine Russo Martin, FMLA, defines and reviews democratic librarianship in her essay, “Democratic Librarianship: The Role of the Medical Library in Promoting Democracy and Social Justice” . ThroughWayne J. Peay, FMLA, and Helen-Ann Brown Epstein, AHIP, FMLA, update the now historic tenth Janet Doe Lecture, which Erich presented in 1977, in their essay, “The Tenth Doe Lecture: A Forty-Year Perspective: Still Relevant after All These Years” . The lecFinally, Stephen J. Greenberg, AHIP, provides a window into the world of historical writing and how it changed over the course of Erich’s life in his essay, “Medical History: As It Was; As It Will Be” . GreenbeThis series of essays honoring Erich Meyerhoff grew out of discussions of the MLA Fellows group during their annual meeting in conjunction with the MLA annual meeting. A small task force was established to define topics for the festschrift essays and engage authors. I thank the members of the Meyerhoff Task Force: Helen-Ann Brown Epstein, AHIP, FMLA, Patricia E. Gallagher, AHIP, FMLA, Stephen J. Greenberg, AHIP, J. Michael Homan, AHIP, FMLA (chair), and Lucretia W. McClure, AHIP, FMLA.J. Michael Homan, AHIP, FMLA,homan@mayo.edu, Emeritus Director of Libraries, Assistant Professor of Biomedical Informatics, and Emeritus Consultant, Health Sciences Research, Mayo Clinic, Rochester, MN


This popular annual session will provide cutting-edge information on what the 116th Congress has and has not accomplished to date, and what may be left for this year. Speakers will discuss key issues such as Social Security, Medicare, Medicaid, and the Older Americans Act, caregiving, the National Institutes of Health. Hill staffers, advocates, and lobbyists will present.


There is an error in the affiliation of author Halina Wiśniewska. The affiliation should be: Institute of Plant Genetics, Polish Academy of Sciences, Poznań, Wielkopolskie Voivodeship, Poland.


The article titled “The Past, Present, and Future of Public Health Surveillance”  was founCastillo-Salgado , which iDeclich and Carter , which iTeutsch and Churchill , which iFreeman et al. , which iBrachman and Thacker , which iMcNabb et al. , which iJohnson and Heymann , which iWork by other authors:Choi , which iChoi and Pak , which iAuthors' own work:


On the basis of pooled data from studies of theNational Heart, Lung and Blood Institute (1995-2012), it is estimated that within oneyear after a first myocardial infarction, 18% of males and 23% of females will die, andthe median survival time is, at ≥ 45 years of age, 8.2 years for males and 5.5for females.3 The underestimation ofcardiovascular risk among women frequently resulted in a more conservative treatment andcontributed to poorer outcomes.4 In thelast decade, several studies have assessed the issue of gender disparities in thediagnosis, treatment, and outcomes of acute coronary syndromes (ACS).2,4 In this context, the study by Soeiro et al.5 contributes to the understanding of thisissue by presenting data from a Brazilian registry of ACS.Coronary artery disease (CAD) was considered, for years, a "male disease”, a concept thatinfluenced diagnostic and clinical decision-making processes.In this multicenter registry, the primary endpoint was in-hospital, all-cause mortality,and the secondary endpoint was the combination of cardiogenic shock, death,reinfarction, ischemic stroke and bleeding during a mean follow-up of 8 months. Justlike any registry, it has limitations, such as the absence of data on other diseaseslike cancer, as well as on the differences in post-discharge management, adherence totreatment, among others, all which might influence survival in any group. Nonetheless,it has a large number of patients  and may offer aninteresting view of the Brazilian scenario of gender differences in ACS.6Unfortunately, data on symptoms at presentation are not available. It is known that, inACS, women are less likely to present with classical angina symptoms, which may lead tounder and/or misdiagnoses in women, and in turn may explain the worse outcomes,particularly in younger women.6,7Accordingly, in the present study, it was noteworthy that percutaneous coronaryinterventions and coronary artery bypass grafting were more frequently performed in menthan in women.Of note, at presentation, women less often had ST-elevation and multivessel CAD than men,but were older and more frequently diabetic, dyslipidemic and hypertensive. These dataare in line with other studies.4,8 On the other hand, similar short-termoutcomes in men and women have also been reported,9 especially after adjustment for clinical differences and theseverity of angiographic disease.10Gaui et al,11 in an analysis ofBrazilian death certificates from 2004 to 2011, reported higher proportional mortalitydue to acute ischemic heart disease in women from the Northeastern region, aged 40-49years, than in men, despite overall lower proportional mortality. Globally, thisdemonstrates that the outcomes of ACS in women are at least equivalent to those of men,if not worse.Regarding outcomes, there were no significant differences between men and women. Thiscontrasts to other studies in which women had worse outcome after ACS, what has beenattributed, among other factors, to older age or the presence of more comorbidities inwomen.The longstanding “knowledge gap” on CAD in women, both on the part of physicians and ofpatients, has created inequalities in healthcare access and processes. However,fortunately, our understanding of gender-specific differences in the initialpresentation, pathophysiology, treatment effectiveness, and clinical outcomes havechanged. The currently presented data are important to underscore the need to increaseknowledge about the importance of CAD in women, so that possible gender biases may beeffectively avoided, and better results obtained for the cardiovascular health ofwomen.


Sociedade Brasileira de Urología (SBU)) was founded in 1926 and in 1974 was launched the Brazilian Journal of Urology , a journal dedicated to publish the research from the Brazilian Urological community.The Brazilian Society of Urology , now a journal to where 2130 authors of 542 institutions from 62 countries have submitted 891 papers in the last 12 months.IBJU is an unique journal because it is an open-access journal which does not charge any fee for submission and/or publication; it is produced inside SBU headquarters and every expenses are supported by the society. Furthermore, it is possible to Brazilian and other Portuguese-speaking urologists to submit their papers in Portuguese and, once approved after peer-review, get a free English version..Luciano A. Favorito, MD, PhD was chosen to be the next Editor-In-Chief and we have been working together in the last two issues.I was elected as Editor-in-Chief in 2012 and this is my last issue since my term will end next December. Last August, 2019, It has been an honor to serve SBU and to conduct this very prestigious journal. It has been a great experience. During the last eight years IBJU's impact factor has risen, the review time has decreased significantly and the journal has attracted higher quality papers.Morais, Bruno A. Nogueira and Patricia Gomes.Editorial process is a team work and I need to thank the support of the successive SBU Board of Directors, to my Associate Editors and to the group responsible for our journal production: Ricardo de Finally, neither peer-review journal is produced without the reviewers; in 2019, 1536 reviewers helped us voluntarily to make an even better journal. As my last act I would like to announce the five most effective reviewers of 2019, based in their review quality, number and time length of review:Alexandre Danilovic, MD, Departamento de Urologia, Hospital das Clínicas da Faculdade de Medicina da USP, SP, Sao Paulo, Brasil; David Hernandez, MD, Department of Urology, University of South Florida, Tampa, FL, USA; Elcio Dias Silva, MD, Clínica Dr. Élcio Dias Silva, Campinas, SP, Brasil; Hubert Swana, MD, Pediatric Urology, Nemours Children's Hospital Orlando, Orlando, FL, USA; Trushar Patel, MD, Department of Urology, University of South Florida, Tampa, FL, USA.See you.


Claude Martin, born in Boulogne-Billancourt, France, in 1949, died at North Hospital, Marseilles, France, on September 2, 2019. Claude qualified from the Marseille School of Medicine in 1979 and was appointed Professor of Anesthesiology and Intensive Care at South Hospital, Marseilles, in 1989. From 1992 to 2015, he chaired the Department of Anesthesiology and Intensive Care of the North Hospital, Marseilles. His life was dedicated to patient care, demanding the best for all patients admitted to our institution, allowing no concessions in terms of the services provided.Claude was an outstanding researcher, publishing his first peer-reviewed paper in 1987 , 3. He aCritical Care.Claude was a former president of the French Society of Anesthesiology and Intensive Care, as well as other national organizations. He was member of several international societies, chairing different sections and leading various projects within his fields of interest. He served as an editor for many journals, notably Outside his distinguished medical career, Claude was passionate about comics, rock music, and culture. His favorite pastime was traveling. He was a model of kindness, humanity, and humor and, despite repeated and ongoing health care problems, always continued his activities with a smile. He will be remembered by us all for his gentle elegance even in times of difficulty. During his final hours, Claude Martin was surrounded by his wonderful family.


It is vital to capture and analyze, from various sources in smart cities, the data that are beneficial in urban planning and decision making for governments and individuals. Urban policy makers can find a suitable solution for urban development by using the opportunities and capacities of big data, and by combining different heterogeneous data resources in smart cities. This paper presents data related to urban computing with an aim of assessing the knowledge that can be obtained through integration of multiple independent data sources in Smart Cities. The data contains multiple sources in the city of Aarhus, Denmark from August 1, 2014 to September 30, 2014. The sources include land use, waterways, water barriers, buildings, roads, amenities, POI, weather, traffic, pollution, and parking lot data. The published data in this paper is an extended version of the City Pulse project data to which additional data sources collected from online sources have been added. The data covers multiple sources in the city of Aarhus, Denmark. The sources are divided into two categories: static and dynamic. Static data sources present data related to land use, waterways, water barriers, buildings, roads, amenities, and POI. Dynamic data sources present weather, traffic, pollution, and parking lot data during the intended period. The association and structure of some data sources of the data are illustrated in The published data in this paper is an extended version of the City Pulse project data 22.1The study period was from August 1, 2014 to September 30, 2014, and took place at Aarhus, Denmark. Aarhus covers an area of 91 square kilometers and has a population of approximately 270,000 inhabitants. Some data sources, such as weather, land use, waterways, water barriers, buildings, roads, amenities, and POI were extracted, collected, and preprocessed from online sources. Moreover, the concentration of various pollutants, parking lots, as well as road traffic data, were taken from the City Pulse project using 217 sensors located in the city. 2.2To study and evaluate the system performance most researches related to urban computing applied a map splitting method and partitioned the evaluating data into segments according to fixed size grids or variable size regions. For the aim of this study, we follow such methods and published the data in this way. Therefore, the city is divided into segments according to one square meter grids and major roads. When the city is divided into one square meter grids, there are 620 grids that cover the whole city.


Scorpions are one of the most important venomous animals in Iran. Their sting has more prevalence in the south and southwest areas. The aim of this study was to introduce their sting agent species in the country.Data were extracted by a mini review on scorpion stinging articles in Iran until early 2018 and then the sting agent species in each area were studied. Geographical and provincial distribution of each species also was provided.Hemiscorpius lepturus, H. acanthocercus and Androctonus crassicauda. Remaining species have not deadly sting but because of their frequency, they encounter the individuals and cause the stinging.Twelve scorpion species are causative agents of sting. According to their deadly rate and clinical symptoms, some of them are considered the most dangerous venomous animals in Iran. Some death cases have been reported because of the sting of 3 species of The highest number of sting agents is in Khuzestan, however Gilan and Mazandaran have the lowest frequency. Because of the high prevalence of sting agent species in that province, the necessity of providing control and prevention programs is very important. Scorpion stinging has been reported in most of the warm areas of the world. These animals belong to the Arthropoda. Scorpion’s geographic distribution is all over the world and the latitude between equator North 50 degree and south 52 degree  but evenIn Iran, the species which sting humans are more opportunist in terms of habitat selection. They use ready spaces and gaps provided in the buildings because of using traditional building materials. This arthropod starts its activities at night and uses its venomous sting to defend or hunt insects to feed. The habitat of most of them is desert and non-residential places –14. SincScorpions are dangerous for humans because of having toxic and deadly sting and for this reason they are medically important so that according to the available statistics, they have the highest human casualties by venomous arthropod in the world , 18. TilSince many species live in Iran but sting of all of them has not been reported, the purpose of this study is introducing the sting agent species and determining their province distribution during the past 50 years in Iran.In this review article, keywords like scorpion, sting agents, dangerous species, provincial distribution, Iran, identification, studies, family and species were used in the sites related to valid medical and health journals, searching in databases like Web of Science, Ovid, PubMed, Systematic Review, SID, Iran Medex, Scirus, Google Scholar and Medline to have access to the articles during 1977 until early 2018. The including criteria for entry in this study articles were as follows, the first all Iranian articles about animal bites were searched. In the next step, they study focused on venomous animal bites and stings. Then the sting agents among of the scorpions were noticed, and then all articles of the scorpion sting agents in the past decades till now have been noticed. Overall, 150 sources were found, but only 75 of these considering the purpose of the study; i.e., report of the sting agent and concentration of study on Iran, 73 sources were surveyed. In addition to the survey of these studies, their application in Iran was done. Then the gained results were provided in tables, graph and figure.Up to now, three scorpion families have been reported in Iran. The sting agent scorpions in Iran include two families of Buthidae and Hemiscorpiidae. They have 12 species from the 8 genus which 10 species belong to Buthidae family and 2 species belong to Hemiscorpiidae family. More than 83.5% of the identified sting agent species in Iran belong to Buthidae family and 16.5% belong to Hemiscorpiidae family , 32, 33.Mesobuthus eupeus are in Ardabil, Kerman, Isfahan, Markazi, Mazandaran, Sistan and Baluchistan, Yazd, Kohgiluyeh and Boyer-Ahmad, Semnan, Fars, Khuzestan, Hormozgan, Golestan, Tehran, Kordistan, Kermanshah, Ilam, west Azarbaijan, Khorasan Razavi and Khorasan Jonoobi. Then, Compsobuthus matthiesseni in Bushehr, Chaharmahal and Bakhtiari, Fars, Hamadan, Kerman, Kohgiluyeh and Boyer-Ahmad, Kordistan, Lorestan, Markazi, Qom, Khuzestan, Hormozgan, Khorasan, Kermanshah, Ilam, west Azarbaijan and Isfahan, Hottentotta saulcyi in Lorestan, Hamadan, Chaharmahal and Bakhtiari, Khuzestan, west Azarbaijan, Kermanshah, Hormozgan, Ilam, Sistan and Balochistan, Kordestan, Kohgiluyeh and Boyer-Ahmad, Fars, Isfahan, Kerman and Ardabil, Odontobuthus doriae in Hormozgan, Kerman, Yazd, Isfahan, Markazi, Ghazvin, Tehran, Alborz, Semnan, west Azerbaijan, Kermanshah, Busher, Hamedan, Hormozgan, Hemiscorpius lepturus in Khuzestan, Semnan, Fars, Kordestan, Hormozgan, Bushehr, Ilam, Lorestan, Kermanshah, Isfahan, Hamedan, Kohgiluyeh and Boyer-Ahmad and Kerman, Orthochirus scrobiculosus in Khuzestan, Hormozgan, Tehran, Sistan and Balochestan, Qom, Isfahan, median (Razavi) Khorasan, Khorasan Jonobi, Gilan, Semnan, Kermanshah, Ilam, Androctonus crassicauda in Bushehr, Semnan, Khuzestan, Ilam, west Azarbaijan, Kordestan, Khorasan Razavi, south Khorasan, Kermanshah, Kerman and Sistan and Balochistan, Mesobuthus or Olivierus caucasicus in west Azarbaijan, Sistan and Balochestan, Isfahan, south Khorasan, Tehran, Markazi and Semnan, Hottentotta jayakari in Qom, Hormozgan and Fars, Hottentotta schach in Fars and Khuzestan, Hemiscorpius acanthocercus in Hormozgan and Apistobuthus pterygocercus in Khuzestan have been reported, respectively 50 is meaHemiscorpius genus includes dangerous and deadly species in the Middle East especially Iran and Iraq and are classified as the most deadly scorpions of the world (The number of scorpion species has been rapidly increasing in the last 3 decades in the world –61. The he world –71. At phe world –75.At present, the most dangerous species of scorpions are in the South and Southwest of Iran. However, completing the data about the sting agent scorpions’ species in Iran needs more efforts of young researchers. Meanwhile, the completion of data in the field of Iran’s sting agent scorpion species and different aspects of it needs cooperation between the physicians of the venomous animal’s sting therapy units and the entomologist in this field. More accurate studies will be done with the cooperation of specialists of different fields about the sting agent species and the clinical effects of each species. This work necessitates a complete research in the country with a similar method and in the provinces and cities. Still, the highest species diversity is seen in the South and Southwest provinces but the diversity of scorpions in the Northeast and Northwest of Iran is less than the Southwest. In high-risk cities and villages, we recommend to the authorities of emergency department of hospitals and treatment centers, to emphasis on having scorpion sting agent by victim companions, because it helps to accurately identify sting agent.


European Congress of NeuroRehabilitation 2019 was held between 9 and 12 October in Budapest and benefited from participation of many neurologists, neurosurgeons, IT specialists, physiotherapists, occupational therapists, kinesiotherapists, logopedists, psychologists, medical assistants, psychiatrists, both from Romania and from abroad.Impairment, disability, handicap: So little done, so much to do”.The central theme was „Similar to previous editions, the congress has maintained its international character, providing experts with a platform in all areas related to neurology and rehabilitation and hosting over 60 sessions with many international speakers -5.The Organizing Committee of the event included personalities such as: Dafin Muresanu – President, Volker Homberg – Program President, Leopold Saltuari, Giorgio Sandrini, Heinrich Biner and Karin Diserens.The event was organized in collaboration with the Bulgarian Society of NeuroRehabilitation, European Academy for Neurology, Romanian Society for Neuropsychological and Motor Rehabilitation, Romanian Society for NeuroRehabilitation, etc.theory and research, evidence based on effectiveness and safety, international validation of the obtained results. He also mentioned the need to develop guides in partnership with the societies in the field and to implement them in the EFNR member societies.In the opening of the congress, Prof. Dafin Muresanu, MD, PhD, approached the subject of changing the philosophy in neurorehabilitation, referring to the three basic pillars: The aim of the congress was to keep the dialogue open between the countries of Europe but also with colleagues in the field, from all over the world.As it is well known, the goal of all neurologists is continuous research, collaboration in order to avoid damage and disability because of brain and cardiovascular diseases, accidents and injuries or functional disorders.Among the novelties of the event were the following: interactive teaching day dedicated to young researchers who took part in the congress; „Ask the expert!” breakfast sessions, in which 10 professors offered their experience, advice and knowledge in two parallel 60-minutes morning sessions; career development, which implied the improvement of knowledge on how to organize a study, how to best write an academic paper, and also how to choose the career path; young experts’ battle, in which young specialists, aged below 35 years, participated in debates that also involved the audience; best oral presentations, implied the presentation of the six best rated abstracts that were presented in 30-minutes lectures.Moreover, among the key topics of the congress were the following: “Impairment vs. compensation oriented approaches in stroke – when to switch”, “New vistas for education in neurorehabilitation in Europe”, “The enigma of “proportional recovery” – impact for neurorehabilitation”, “Innovative strategies for neurorehabilitation trials”, “The rationales of cognitive training strategies”.


In this data article, a thorough dataset on patterns of electricity use in Nigerian public universities was presented. Three relatively old public universities with staff and students’ halls of residences were purposively selected. The selected universities were Obafemi Awolowo University, Ile-Ife (OAU), Federal University of Technology, Akure (FUTA), and University of Ibadan (UI). Data were obtained through the administration of a structured questionnaire on electricity end users in the universities sampled. For the data collection, the electricity end users in public universities were stratified into users in university staff offices, staff residences, student residences, and commercial units. Electricity users were selected using systematic random sampling and accidental sampling techniques. In OAU, FUTA and UI, 217, 137 and 164 students, respectively were sampled; 30, 3, and 61 households in OAU, FUTA, and UI, respectively were sampled while 28, 6, and 18 commercial units in OAU, FUTA and UI, respectively were also sampled. The sample size determined for staff in OAU, FUTA and UI were 139, 81 and 182, respectively. The data obtained were analyzed using radar charts. The information provided in this data article will encourage investigation into electricity management strategies, critical success factors for electricity management, planning, and policy formulation towards the realization of sustainable campuses. Specification tableValue of the data•The data will foster more empirical investigation for a better understanding of areas of improvement in electricity use •The data provided in this article is useful for the development of electricity use models, energy audit, and energy management practices •The data provided will assist the government and the management of public universities in result-oriented planning, budgeting, and decision-making •The provision of this data will propel the achievement of the sustainable campus environment 1The patterns of electricity consumption were demonstrated from different perspectives , Fig. 8.2The quantitative technique was adopted. The instrument for data collection was a structured questionnaire. A multi-stage sampling technique was used for the data collection The populations of students occupying these hostels earlier determined were 1228, 1200 and 1618 for Moremi, Jadesola Akande and Awolowo halls, respectively; 2,032, 1142 and 956 for Awolowo, Peter Adeniyi and Independence halls, respectively, while there were 1072 , 400  and 700  in Murtala Muhammed, FUTA and Abdusalam Abubakar Postgraduate halls, respectively. One out of every twenty (5%) students were selected in each hall. In all, 217, 137 and 164 students were sampled in OAU, FUTA, and UI, respectively. The preliminary investigation also showed that in OAU, FUTA, and UI, there were 600, 50 and 1212 households, respectively in staff residential quarters while there were 552, 115 and 350 shops, respectively to constitute the sample frame for both staff housing units and business units. One out of every twenty (5%) households and shops were selected. Using this method, 30, 3 and 61 households in OAU, FUTA, and UI, respectively were sampled while 28, 6 and 18 business units in OAU, FUTA, and UI, respectively were also sampled. For staff offices, accidental sampling was used across academic, administrative and other cadres of staff in the three universities. The sample size determined for staff in OAU, FUTA and UI were 139, 81 and 182, respectively.The amount of electricity consumption was calculated from Eq.


After publication of this article, the authors became aware of an error in the quoted number of philosophical-belief vaccine nonmedical exemptions (NMEs) in Allegheny County, Pennsylvania. The quoted number of 424 exemptions resulted from an inadvertent doubling of the correct number of 212. The authors apologize for this error. All the data and analyses in the paper have now been thoroughly checked, and we can verify that, while the error affected all entries in the Pennsylvania county-level dataset, no data from other states were affected. Therefore, the authors would like to correct the text and figures of the article as follows, to remove Allegheny County from the maps and rankings of areas with >400 kindergarteners with NMEs in 2016-2017. In addition to Allegheny County, NME rates for all counties in Pennsylvania have been corrected in There were also two minor errors in presentation that need to be corrected, regarding the list of states in the second summary point and an asterisk missing from The first sentence of the second Summary point should read “Since 2009, the number of philosophical-belief vaccine nonmedical exemptions (NMEs) has risen in 12 of the 18 states that currently allow this policy: Arizona (AZ), Arkansas (AR), Idaho (ID), Maine (ME), Minnesota (MN), Missouri (MO), North Dakota (ND), Ohio (OH), Oklahoma (OK), Oregon (OR), Texas (TX), and Utah (UT).”We would also like to amend the third Summary point, to substitute the names of the counties from which data were derived for the names of cities within those counties. The first sentence of the third Summary point should read “Several US “hotspot” metropolitan areas stand out for their very large numbers of NMEs. They include King County, WA, Spokane County, WA, and Multnomah County, OR, in the Northwest; Maricopa County, AZ, Salt Lake County, UT, Utah County, UT, Harris County, TX, Tarrant County, TX, Collin County, TX, and Travis County, TX, in the Southwest; and Oakland County, MI, Macomb County, MI, Wayne County, MI, and Jackson County, MO, in the Midwest.”The third paragraph of the section subtitled “Going granular” should read “Furthermore, we examined total numbers of kindergarteners with NMEs per county to identify focal areas with large numbers of potentially vulnerable pediatric populations. County NME totals were also provided by state health departments. The exception is MO, whose private kindergarten (2015–2016) and public kindergarten (2014–2015) enrollment numbers were taken together from the National Center for Education Statistics (nces.ed.gov) to derive NME raw counts. Shown in In The penultimate line in the second paragraph of the Discussion should be “Our analysis identified the following hotspot metropolitan areas: Seattle, WA, Spokane, WA, and Portland, OR in the Northwest; Phoenix, AZ, Salt Lake City, UT, Provo, UT, Houston, TX, Fort Worth, TX, Plano, TX, and Austin, TX in the Southwest; Troy, MI, Warren, MI, Detroit, MI, and Kansas City, MO in the Midwest.”The Acknowledgments should read: We would like to acknowledge the following state health departments that provided us with data wherever possible: AR Department of Health, ID Department of Health and Welfare, LA Department of Health, MO Department of Health and Senior Services, ND Department of Health, OR Health Authority, TX Department of State Health Services, UT Department of Health, and WI Department of Health Services.